Skip Page Header

Home > The case for increasing buprenorphine use as OST during Covid-19.

Somers, Ciaran (2021) The case for increasing buprenorphine use as OST during Covid-19. Irish Pharmacist , February 2021 .

External website: https://irishpharmacist.ie/2021/02/01/the-case-for...

[Please note, the Irish Pharmacist website (and the full text of this article) is for health professionals only.]

Consultant in Addiction Psychiatry Dr Ciaran Somers analyses the potential advantages of an accelerated move to buprenorphine from methadone in pharmacies and GP clinics during Covid-19

In the context of the Covid-19 pandemic and difficulties encountered with supplying clients on opioid substitution therapy (OST) with their regular methadone dose, I present a case for the accelerated introduction of buprenorphine as an alternative to methadone OST in Ireland. As of September 2020, there were 376 clients prescribed buprenorphine in Ireland, as compared to almost 10,000 remaining on methadone. Factors in favour of buprenorphine include safer delivery, shorter duration of titration to a therapeutic dose, and a better side-effect profile relative to methadone......


Repository Staff Only: item control page